These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10505105)

  • 41. Interferon-alpha and interleukin-12 gene therapy of cancer: interferon-alpha induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing.
    Eguchi J; Hiroishi K; Ishii S; Mitamura K
    Cancer Immunol Immunother; 2003 Jun; 52(6):378-86. PubMed ID: 12739068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer.
    Suzuki K; Nakazato H; Matsui H; Hasumi M; Shibata Y; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
    J Leukoc Biol; 2001 Apr; 69(4):531-7. PubMed ID: 11310838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma.
    Ju DW; Tao Q; Cheng DS; Zhang W; Zhang M; Hamada H; Cao X
    Gene Ther; 2000 Feb; 7(4):329-38. PubMed ID: 10694814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer.
    Martinet O; Divino CM; Zang Y; Gan Y; Mandeli J; Thung S; Pan PY; Chen SH
    Gene Ther; 2002 Jun; 9(12):786-92. PubMed ID: 12040460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model.
    Imagawa Y; Satake K; Kato Y; Tahara H; Tsukuda M
    Auris Nasus Larynx; 2004 Sep; 31(3):239-45. PubMed ID: 15364358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases.
    Worth LL; Jia SF; Zhou Z; Chen L; Kleinerman ES
    Clin Cancer Res; 2000 Sep; 6(9):3713-8. PubMed ID: 10999765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combined gene therapy for murine liver cancer with interleukin-18 and cytosine deaminase genes].
    Sun W; Tang Z; Wei D; Tang Y; Chen S
    Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):300-2. PubMed ID: 11676879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-dependent improvements in outcome with adenoviral expression of interleukin-10 in a murine model of multisystem organ failure.
    McAuliffe PF; Murday ME; Efron PA; Scumpia PO; Ungaro R; Abouhamze A; Tannahill CL; Hutchins B; LaFace D; Moldawer LL
    Gene Ther; 2006 Feb; 13(3):276-82. PubMed ID: 16251998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12.
    Mazzolini G; Narvaiza I; Pérez-Diez A; Rodriguez-Calvillo M; Qian C; Sangro B; Ruiz J; Prieto J; Melero I
    Gene Ther; 2001 Feb; 8(4):259-67. PubMed ID: 11313799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
    Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
    Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy.
    Pappo I; Tahara H; Robbins PD; Gately MK; Wolf SF; Barnea A; Lotze MT
    J Surg Res; 1995 Feb; 58(2):218-26. PubMed ID: 7861776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response.
    Adris S; Klein S; Jasnis M; Chuluyan E; Ledda M; Bravo A; Carbone C; Chernajovsky Y; Podhajcer O
    Gene Ther; 1999 Oct; 6(10):1705-12. PubMed ID: 10516719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
    Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
    Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model.
    Ishii S; Hiroishi K; Eguchi J; Hiraide A; Imawari M
    Gene Ther; 2006 Jan; 13(1):78-87. PubMed ID: 16107857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity.
    Mendiratta SK; Quezada A; Matar M; Wang J; Hebel HL; Long S; Nordstrom JL; Pericle F
    Gene Ther; 1999 May; 6(5):833-9. PubMed ID: 10505108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness.
    Govaerts AS; Guillaume T; André M; Bayat B; Feyens AM; Hawley TS; Fong AZ; Hawley RG; Symann M
    Cancer Gene Ther; 1999; 6(5):447-55. PubMed ID: 10505855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.